Copyright
©2010 Baishideng. All rights reserved.
World J Gastrointest Oncol. May 15, 2010; 2(5): 229-234
Published online May 15, 2010. doi: 10.4251/wjgo.v2.i5.229
Published online May 15, 2010. doi: 10.4251/wjgo.v2.i5.229
Perspectives on the treatment of colorectal carcinoma
Ren Zhao, Jing Li, Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University, Shanghai 200025, China
Author contributions: Zhao R and Li J analyzed the data, and wrote the paper.
Correspondence to: Ren Zhao, MD, PhD, Department of General Surgery, Ruijin Hospital, Shanghai Jiaotong University, No.197 Ruijin Er Road, Shanghai 200025, China. zhaorensurgeon@yahoo.cn
Telephone: +86-21-64370045 Fax: +86-21-64378172
Received: November 4, 2009
Revised: December 14, 2009
Accepted: December 21, 2009
Published online: May 15, 2010
Revised: December 14, 2009
Accepted: December 21, 2009
Published online: May 15, 2010
Abstract
Colorectal cancer includes cancerous growths in the colon, rectum and appendix. With 655000 deaths worldwide per year, it is the third most common form of cancer and the second leading cause of cancer-related death in the Western world. Advances in imaging, genetics, molecular diagnostics, surgical techniques and chemotherapy are now making significant gains in our ability to prevent, diagnose, and treat this serious disease. This article reviews some of these recent successes and shares a vision of future care based on current research.
Keywords: Treatment, Colorectal carcinoma, Resection margin, Chemotherapy, Chemoprevention, Screening technology, Endoscopic submucosal surgery